US Oncology's expertise in supporting every aspect of the cancer care delivery system - from drug development to treatment and outcomes measurement, enables the company to help increase the efficiency and safety of cancer care. US Oncology is affiliated with 1,227 physicians operating in 485 locations, including 92 radiation oncology facilities in 39 states. For more information, visit the company's Web site, http://www.usoncology.com.
This news release contains forward-looking statements, including
statements that include the words "believes," "expects," "anticipates,"
"estimates," "intends," "plans," "projects," or similar expressions and
statements regarding our prospects. All statements other than statements of
historical fact included in this news release are forward-looking
statements. Although the Company believes that the expectations reflected
in such statements are reasonable, it can give no assurance that such
expectations will prove to have been correct. Such expectations are subject
to risks and uncertainties, including a general downturn in the U.S. or
global economy, the Company's reliance on pharmaceuticals for the majority
of its revenues, the Company's ability to maintain favorable pharmaceutical
pricing and favorable relationships with pharmaceutical manufacturers and
other vendors, concentration of pharmaceutical purchasing and favorable
pricing with a limited number of vendors, prescription drug reimbursement,
such as reimbursement for ESAs, and other reimbursement under Medicare
(including reimbursement for radiation and diagnostic services),
reimbursement for medical services by non-governmental payers and
|SOURCE US Oncology, Inc.|
Copyright©2008 PR Newswire.
All rights reserved